Stimulation of A2B adenosine receptors protects against trauma-hemorrhagic shock-induced lung injury

Purinergic Signalling

Volumn 9, Issue 3, 2013, Pages 427-432

  Koscsó, Balázs ^a   Trepakov, Alexey ^a   Csóka, Balázs ^a   Németh, Zoltán H ^c   Pacher, Pál ^d   Eltzschig, Holger K ^b   Haskó, György ^a,e  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c MORRISTOWN MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^e UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

A2B adenosine receptor; BAY 60 6583; Hemorrhagic shock; Trauma

Indexed keywords

ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; ALANINE AMINOTRANSFERASE; BAY 60 6583; CREATINE KINASE; I KAPPA B ALPHA; MYELOPEROXIDASE; RINGER LACTATE SOLUTION; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR STIMULATING AGENT; AMINOPYRIDINE DERIVATIVE; BAY 60-6583;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HEMORRHAGIC SHOCK; LUNG INJURY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERMEABILITY; PNEUMONIA; PROTEIN ISOLATION; RAT; STIMULATION; WESTERN BLOTTING; ACUTE LUNG INJURY; ANIMAL; DISEASE MODEL; INFLAMMATION; INJURY; METABOLISM; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; AMINOPYRIDINES; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; PURINERGIC P1 RECEPTOR AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2B; SHOCK, HEMORRHAGIC; WOUNDS AND INJURIES;

EID: 84883455757     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-013-9362-7     Document Type: Article

References (30)

1. Hierholzer C, Billiar TR (2001) Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 386(4): 302-308.
2. Deitch EA (1992) Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216(2): 117-134.
3. Bours MJL, Swennen ELR, Di Virgilio F, Cronstein BN, Dagnelie PC (2006) Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112(2): 358-404.
4. Hasko G, Deitch EA, Szabo C, Nemeth ZH, Vizi ES (2002) Adenosine: a potential mediator of immunosuppression in multiple organ failure. Curr Opin Pharmacol 2(4): 440-444.
5. Hasko G, Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25(1): 33-39.
6. Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R (1983) Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158(4): 1160-1177.
7. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4): 527-552.
8. Hasko G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7(9): 759-770. doi: 10. 1038/nrd2638.
9. Hasko G, Pacher P, Deitch EA, Vizi ES (2007) Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther 113(2): 264-275. doi: 10. 1016/j. pharmthera. 2006. 08. 003.
10. Hasko G, Pacher P (2012) Regulation of macrophage function by adenosine. Arterioscler Thromb Vasc Biol 32(4): 865-869. doi: 10. 1161/ATVBAHA. 111. 226852.
11. Hasko G, Xu DZ, Lu Q, Nemeth ZH, Jabush J, Berezina TL, Zaets SB, Csoka B, Deitch EA (2006) Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock. Crit Care Med 34(4): 1119-1125. doi: 10. 1097/01. CCM. 0000206467. 19509. C6.
12. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK (2007) Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115(12): 1581-1590. doi: 10. 1161/CIRCULATIONAHA. 106. 669697.
13. Hart ML, Jacobi B, Schittenhelm J, Henn M, Eltzschig HK (2009) Cutting edge: A2B adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol 182(7): 3965-3968. doi: 10. 4049/jimmunol. 0802193.
14. Schingnitz U, Hartmann K, Macmanus CF, Eckle T, Zug S, Colgan SP, Eltzschig HK (2010) Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol 184(9): 5271-5279. doi: 10. 4049/jimmunol. 0903035.
15. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK (2008) A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111(4): 2024-2035. doi: 10. 1182/blood-2007-10-117044.
16. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK (2009) Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10(2): 195-202. doi: 10. 1038/ni. 1683.
17. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K (2006) The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116(7): 1913-1923. doi: 10. 1172/JCI27933.
18. Eckle T, Grenz A, Laucher S, Eltzschig HK (2008) A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 118(10): 3301-3315. doi: 10. 1172/JCI34203.
19. Lehnert M, Relja B, Sun-Young Lee V, Schwestka B, Henrich D, Czerny C, Froh M, Borsello T, Marzi I (2008) A peptide inhibitor of C-jun N-terminal kinase modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation. Shock 30(2): 159-165. doi: 10. 1097/SHK. 0b013e31815dd623.
20. Sato H, Tanaka T, Kasai K, Kita T, Tanaka N (2007) Role of p38 mitogen-activated protein kinase on cardiac dysfunction after hemorrhagic shock in rats. Shock 28(3): 291-299. doi: 10. 1097/SHK. 0b013e3180326e3d.
21. Korff S, Falsafi R, Czerny C, Jobin C, Nau C, Jakob H, Marzi I, Lehnert M (2012) Time dependency and topography of hepatic nuclear factor kappaB activation after hemorrhagic shock and resuscitation in mice. Shock 38(5): 486-492. doi: 10. 1097/SHK. 0b013e3182699072.
22. Kalk P, Eggert B, Relle K, Godes M, Heiden S, Sharkovska Y, Fischer Y, Ziegler D, Bielenberg GW, Hocher B (2007) The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure. Br J Pharmacol 151(7): 1025-1032. doi: 10. 1038/sj. bjp. 0707319.
23. Eckle T, Hartmann K, Bonney S, Reithel S, Mittelbronn M, Walker LA, Lowes BD, Han J, Borchers CH, Buttrick PM, Kominsky DJ, Colgan SP, Eltzschig HK (2012) Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med 18(5): 774-782. doi: 10. 1038/nm. 2728.
24. Thourani VH, Ronson RS, Jordan JE, Guyton RA, Vinten-Johansen J (1999) Adenosine A3 pretreatment before cardioplegic arrest attenuates postischemic cardiac dysfunction. Ann Thorac Surg 67(6): 1732-1737.
25. Thourani VH, Nakamura M, Ronson RS, Jordan JE, Zhao ZQ, Levy JH, Szlam F, Guyton RA, Vinten-Johansen J (1999) Adenosine A(3)-receptor stimulation attenuates postischemic dysfunction through K(ATP) channels. Am J Physiol 277(1 Pt 2): H228-H235.
26. Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, Vizi ES (1996) Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264. 7 macrophages and in endotoxemic mice. J Immunol 157(10): 4634-4640.
27. Hasko G, Kuhel DG, Chen JF, Schwarzschild MA, Deitch EA, Mabley JG, Marton A, Szabo C (2000) Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 14(13): 2065-2074. doi: 10. 1096/fj. 99-0508com.
28. Csoka B, Nemeth ZH, Virag L, Gergely P, Leibovich SJ, Pacher P, Sun CX, Blackburn MR, Vizi ES, Deitch EA, Hasko G (2007) A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. Blood 110(7): 2685-2695. doi: 10. 1182/blood-2007-01-065870.
29. Kobbe P, Schmidt J, Stoffels B, Chanthaphavong RS, Bauer AJ, Pape HC (2009) IL-10 administration attenuates pulmonary neutrophil infiltration and alters pulmonary iNOS activation following hemorrhagic shock. Inflamm Res Off J Eur Hist Res Soc 58(3): 170-174. doi: 10. 1007/s00011-009-8116-z.
30. Kobbe P, Stoffels B, Schmidt J, Tsukamoto T, Gutkin DW, Bauer AJ, Pape HC (2009) IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock. Cytokine 45(1): 26-31. doi: 10. 1016/j. cyto. 2008. 10. 004.